L’Assurance maladie points out the “weight of chronic diseases” in health spending – 20/06/2022 at 17:16

A few days after an expected report on his savings, the director of health insurance, Thomas Fatôme, pointed out on Monday “the weight of chronic diseases” in his expenses, whose data by pathology will be accessible from Tuesday via an open data site.

The trend is confirmed year after year: “we see a concentration of health spending around chronic diseases,” said Mr. Fatome during a press presentation of the new site “Data pathologies” tracing the reimbursements for 57 categories of diseases, by region or department, from 2015 to 2020.

The latest figures show that a total of 168 billion is spent on the care of more than 66 million patients, of which 104 billion are for chronic diseases, or 62%.

Part of the progression of a report point with 2019, essential due to the fall of “one-off” hospitalizations during the confinements due to the first waves of Covid-19.

But the analysis for several years highlights “extremely heavy factors that are pushing up,” Fatome said. In five years, the number of patients has increased by 440,000 for diabetes and 540,000 for cardiovascular diseases.

At the same time, the cost of treatments has jumped from 18% for “active cancers” and up to 50% for lung cancer, with the arrival of new treatments such as immunotherapy. “It’s good news for patient care,” he said, adding that he was “not here to say it’s too expensive, but to make it clear.”

A kind of land preparation before the annual report “Expenses and products”, which aims to propose to the government ways to control health spending, upstream of the budget of the Secu presented in the fall.

Without deflecting his expected proposals in late June or early July, he said that “the debate on health policy is all the more relevant because it is based on stagnant data,” adding that “our responsibility is to provoke this debate.” “. “.

.

Leave a Comment